Skip to main content
Top
Published in: Journal of Translational Medicine 1/2019

Open Access 01-12-2019 | ST-Segment Elevation Myocardial Infarction | Research

Characteristics of T cell receptor repertoires of patients with acute myocardial infarction through high-throughput sequencing

Authors: Zhixiong Zhong, Heming Wu, Qifeng Zhang, Wei Zhong, Pingsen Zhao

Published in: Journal of Translational Medicine | Issue 1/2019

Login to get access

Abstract

Background

T cells are key regulators of immunity and one of the cells recruited in atherosclerosis and participated in various stages of the development of atherosclerosis. Characterizing T-cell receptor (TCR) repertoires is a priority of great scientific interest and potential clinical utility for the early diagnosis, risk stratification and prognostic evaluation of acute myocardial infarction (AMI).

Methods

The TCR repertoires in 21 subjects including 7 patients with non-ST-segment elevation myocardial infarction (NSTEMI), 6 patients with ST-segment elevation myocardial infarction (STEMI) and 8 subjects with normal coronary artery (NCA) as control were characterized by using high-throughput sequencing. Bioinformatics analysis were performed.

Results

Patients with NSTEMI displayed more diverse TCR sequences than NCA controls, but they had lower percentage of top 200 TCR sequences. However, no significant differences were observed between the patients with STEMI and NCA controls, but STEMI group had lower percentage of top 200 TCR sequences. T cells from patients with AMI and NCA controls showed a differential V and J gene usage, especially, significant difference was observed in frequencies of V gene (TRBV2, TRBV29-1, TRBV30 and TRBV12-3) and J gene (TRBJ2-1) usage. Furthermore, significantly differences in average overlap was observed in groups of AMI and NCA control. The results showed that patients with AMI had distinct TCR repertoires which revealed the association between cardiovascular condition and T-cell clonotypes.

Conclusions

Our findings revealed the differences of TCR repertoires between patients with AMI and NCA controls, which might be potential biomarkers for evaluating risk stratification or diagnosis of acute coronary syndrome.
Appendix
Available only for authorised users
Literature
1.
go back to reference Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.PubMed Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation. 2013;127:e6–245.PubMed
2.
go back to reference Bugiardini R. Risk stratification in acute coronary syndrome: focus on unstable angina/non-ST segment elevation myocardial infarction. Heart. 2004;90:729–31.CrossRef Bugiardini R. Risk stratification in acute coronary syndrome: focus on unstable angina/non-ST segment elevation myocardial infarction. Heart. 2004;90:729–31.CrossRef
3.
go back to reference Lakhani MS, Qadir F, Hanif B, et al. Correlation of thrombolysis in myocardial infarction (TIMI) risk score with extent of coronary artery disease in patients with acute coronary syndrome. J Pak Med Assoc. 2010;60:197–200.PubMed Lakhani MS, Qadir F, Hanif B, et al. Correlation of thrombolysis in myocardial infarction (TIMI) risk score with extent of coronary artery disease in patients with acute coronary syndrome. J Pak Med Assoc. 2010;60:197–200.PubMed
4.
go back to reference Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129:1493–501.CrossRef Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129:1493–501.CrossRef
5.
go back to reference Jones BM, Kapadia SR, Smedira NG, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 2014;35:2060–8.CrossRef Jones BM, Kapadia SR, Smedira NG, et al. Ventricular septal rupture complicating acute myocardial infarction: a contemporary review. Eur Heart J. 2014;35:2060–8.CrossRef
6.
go back to reference Yasmeen F, Ghafoor MB, Khalid AW, et al. Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR. J Thromb Thrombolysis. 2015;40:218–24.CrossRef Yasmeen F, Ghafoor MB, Khalid AW, et al. Analysis of CYP2C9 polymorphisms (*2 and *3) in warfarin therapy patients in Pakistan. Association of CYP2C9 polymorphisms (*2 and*3) with warfarin dose, age, PT and INR. J Thromb Thrombolysis. 2015;40:218–24.CrossRef
7.
go back to reference Zhao P, Wu H, Zhong Z, et al. Expression profiles of long noncoding RNAs and mRNAs in peripheral blood mononuclear cells of patients with acute myocardial infarction. Medicine. 2018;97:e12604.CrossRef Zhao P, Wu H, Zhong Z, et al. Expression profiles of long noncoding RNAs and mRNAs in peripheral blood mononuclear cells of patients with acute myocardial infarction. Medicine. 2018;97:e12604.CrossRef
8.
go back to reference Zhong Z, Hou J, Zhang Q, et al. Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease. Medicine. 2018;97:e11428.CrossRef Zhong Z, Hou J, Zhang Q, et al. Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease. Medicine. 2018;97:e11428.CrossRef
9.
go back to reference Novak J, Dobrovolny J, Tousek P, et al. Potential role of invariant natural killer T cells in outcomes of acute myocardial infarction. Int J Cardiol. 2015;187:663–5.CrossRef Novak J, Dobrovolny J, Tousek P, et al. Potential role of invariant natural killer T cells in outcomes of acute myocardial infarction. Int J Cardiol. 2015;187:663–5.CrossRef
10.
go back to reference Hogquist KA, Jameson SC, Heath WR, et al. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17–27.CrossRef Hogquist KA, Jameson SC, Heath WR, et al. T cell receptor antagonist peptides induce positive selection. Cell. 1994;76:17–27.CrossRef
11.
go back to reference Wu LC, Tuot DS, Lyons DS, et al. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature. 2002;418:552–6.CrossRef Wu LC, Tuot DS, Lyons DS, et al. Two-step binding mechanism for T-cell receptor recognition of peptide MHC. Nature. 2002;418:552–6.CrossRef
12.
go back to reference Choudhuri K, Wiseman D, Brown MH, et al. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature. 2005;436:578–82.CrossRef Choudhuri K, Wiseman D, Brown MH, et al. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature. 2005;436:578–82.CrossRef
13.
go back to reference Jia L, Zhu L, Wang JZ, et al. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease. Atherosclerosis. 2013;228:346–52.CrossRef Jia L, Zhu L, Wang JZ, et al. Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease. Atherosclerosis. 2013;228:346–52.CrossRef
14.
go back to reference Lin YZ, Lu SH, Lu ZD, et al. Downregulation of CD4+ LAP+ and CD4+ CD25+ regulatory T cells in acute coronary syndromes. Mediators Inflamm. 2013;2013:764082.PubMedPubMedCentral Lin YZ, Lu SH, Lu ZD, et al. Downregulation of CD4+ LAP+ and CD4+ CD25+ regulatory T cells in acute coronary syndromes. Mediators Inflamm. 2013;2013:764082.PubMedPubMedCentral
15.
go back to reference Jonasson L, Holm J, Skalli O, et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131–8.CrossRef Jonasson L, Holm J, Skalli O, et al. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986;6:131–8.CrossRef
16.
go back to reference Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J. 1993;69:S38.CrossRef Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. Br Heart J. 1993;69:S38.CrossRef
17.
go back to reference Witztum JL, Lichtman AH. The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol. 2014;9:73–102.CrossRef Witztum JL, Lichtman AH. The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol. 2014;9:73–102.CrossRef
18.
go back to reference Wick G, Kleindienst R, Dietrich H, et al. Is atherosclerosis an autoimmune disease? BMC Med. 2014;12:47.CrossRef Wick G, Kleindienst R, Dietrich H, et al. Is atherosclerosis an autoimmune disease? BMC Med. 2014;12:47.CrossRef
19.
go back to reference Chistiakov DA, Orekhov AN, Bobryshev YV. Immune-inflammatory responses in atherosclerosis: role of an adaptive immunity mainly driven by T and B cells. Immunobiology. 2016;221:1014–33.CrossRef Chistiakov DA, Orekhov AN, Bobryshev YV. Immune-inflammatory responses in atherosclerosis: role of an adaptive immunity mainly driven by T and B cells. Immunobiology. 2016;221:1014–33.CrossRef
20.
go back to reference Arbabzadeh A, Nakano M, Virmani R, et al. Acute coronary events. Circulation. 2012;125:1147–56.CrossRef Arbabzadeh A, Nakano M, Virmani R, et al. Acute coronary events. Circulation. 2012;125:1147–56.CrossRef
21.
go back to reference Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–9.CrossRef Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801–9.CrossRef
22.
go back to reference Wick G, Schett G, Amberger A, et al. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995;16:27.CrossRef Wick G, Schett G, Amberger A, et al. Is atherosclerosis an immunologically mediated disease? Immunol Today. 1995;16:27.CrossRef
23.
go back to reference Woodsworth DJ, Castellarin M, Holt RA. Sequence analysis of T-cell repertoires in health and disease. Genome Med. 2013;5:98.CrossRef Woodsworth DJ, Castellarin M, Holt RA. Sequence analysis of T-cell repertoires in health and disease. Genome Med. 2013;5:98.CrossRef
24.
go back to reference Chen Y, Xu Y, Zhao M, et al. High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC. Oncoimmunology. 2016;5:e1219010.CrossRef Chen Y, Xu Y, Zhao M, et al. High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC. Oncoimmunology. 2016;5:e1219010.CrossRef
25.
go back to reference Liaskou E, Klemsdal Henriksen EK, Holm K, et al. High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires. Hepatology. 2016;63:1608–19.CrossRef Liaskou E, Klemsdal Henriksen EK, Holm K, et al. High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires. Hepatology. 2016;63:1608–19.CrossRef
26.
go back to reference Han Y, Liu X, Wang Y, et al. Identification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysis. Oncoimmunology. 2015;4:e1021537.CrossRef Han Y, Liu X, Wang Y, et al. Identification of characteristic TRB V usage in HBV-associated HCC by using differential expression profiling analysis. Oncoimmunology. 2015;4:e1021537.CrossRef
27.
go back to reference Chen XM, Zhang T, Qiu D, et al. Gene expression pattern of TCR repertoire and alteration expression of IL-17A gene of gammadelta T cells in patients with acute myocardial infarction. J Transl Med. 2018;16:189.CrossRef Chen XM, Zhang T, Qiu D, et al. Gene expression pattern of TCR repertoire and alteration expression of IL-17A gene of gammadelta T cells in patients with acute myocardial infarction. J Transl Med. 2018;16:189.CrossRef
28.
go back to reference Munier CM, Kelleher AD, Kent SJ, et al. The role of T cell immunity in HIV-1 infection. Curr Opin Virol. 2013;3:438–46.CrossRef Munier CM, Kelleher AD, Kent SJ, et al. The role of T cell immunity in HIV-1 infection. Curr Opin Virol. 2013;3:438–46.CrossRef
29.
go back to reference Alroqi FJ, Chatila TA. T regulatory cell biology in health and disease. Curr Allergy Asthma Rep. 2016;16:27.CrossRef Alroqi FJ, Chatila TA. T regulatory cell biology in health and disease. Curr Allergy Asthma Rep. 2016;16:27.CrossRef
30.
go back to reference Allan RS, Nutt SL. Deciphering the epigenetic code of T lymphocytes. Immunol Rev. 2014;261:50–61.CrossRef Allan RS, Nutt SL. Deciphering the epigenetic code of T lymphocytes. Immunol Rev. 2014;261:50–61.CrossRef
31.
go back to reference van de Linde P, Roep BO. T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes. Am J Ther. 2005;12:573–9.CrossRef van de Linde P, Roep BO. T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes. Am J Ther. 2005;12:573–9.CrossRef
32.
go back to reference Crea F, Liuzzo G. Pathogenesis of acute coronary syndromes. J Am Coll Cardiol. 2013;61:1–11.CrossRef Crea F, Liuzzo G. Pathogenesis of acute coronary syndromes. J Am Coll Cardiol. 2013;61:1–11.CrossRef
33.
go back to reference Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135–9.CrossRef Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135–9.CrossRef
34.
go back to reference Liuzzo G, Goronzy JJ, Yang H, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883–8.CrossRef Liuzzo G, Goronzy JJ, Yang H, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883–8.CrossRef
35.
go back to reference Liuzzo G, Montone RA, Gabriele M, et al. Identification of unique adaptive immune system signature in acute coronary syndromes. Int J Cardiol. 2013;168:564–7.CrossRef Liuzzo G, Montone RA, Gabriele M, et al. Identification of unique adaptive immune system signature in acute coronary syndromes. Int J Cardiol. 2013;168:564–7.CrossRef
36.
go back to reference Flego D, Liuzzo G, Weyand CM, et al. Adaptive immunity dysregulation in acute coronary syndromes: from cellular and molecular basis to clinical implications. J Am Coll Cardiol. 2016;68:2107–17.CrossRef Flego D, Liuzzo G, Weyand CM, et al. Adaptive immunity dysregulation in acute coronary syndromes: from cellular and molecular basis to clinical implications. J Am Coll Cardiol. 2016;68:2107–17.CrossRef
37.
go back to reference Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204.CrossRef Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204.CrossRef
38.
go back to reference Ozaki Y, Imanishi T, Taruya A, et al. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris. Circ J. 2012;76:2412.CrossRef Ozaki Y, Imanishi T, Taruya A, et al. Circulating CD14+CD16+ monocyte subsets as biomarkers of the severity of coronary artery disease in patients with stable angina pectoris. Circ J. 2012;76:2412.CrossRef
39.
go back to reference Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995;92:748–55.CrossRef Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995;92:748–55.CrossRef
40.
go back to reference Spagnoli LG, Bonanno E, Mauriello A, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2002;40:1579–88.CrossRef Spagnoli LG, Bonanno E, Mauriello A, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol. 2002;40:1579–88.CrossRef
41.
go back to reference Suleiman M, Khatib R, Agmon Y, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47:962–8.CrossRef Suleiman M, Khatib R, Agmon Y, et al. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction: predictive role of C-reactive protein. J Am Coll Cardiol. 2006;47:962–8.CrossRef
42.
go back to reference Yoshizaki T, Umetani K, Ino Y, et al. Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction. Intern Med. 2012;51:1467–71.CrossRef Yoshizaki T, Umetani K, Ino Y, et al. Activated inflammation is related to the incidence of atrial fibrillation in patients with acute myocardial infarction. Intern Med. 2012;51:1467–71.CrossRef
43.
go back to reference Engler RL, Dahlgren MD, Morris DD, et al. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986;251:314–23. Engler RL, Dahlgren MD, Morris DD, et al. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986;251:314–23.
44.
go back to reference Henning RJ, Shariff M, Eadula U, et al. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction. Stem Cells Dev. 2008;17:1207.CrossRef Henning RJ, Shariff M, Eadula U, et al. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction. Stem Cells Dev. 2008;17:1207.CrossRef
45.
go back to reference Wu Y, Xin T, Lin G, et al. Emodin-mediated protection from acute myocardial infarction via inhibition of inflammation and apoptosis in local ischemic myocardium. Life Sci. 2007;81:1332.CrossRef Wu Y, Xin T, Lin G, et al. Emodin-mediated protection from acute myocardial infarction via inhibition of inflammation and apoptosis in local ischemic myocardium. Life Sci. 2007;81:1332.CrossRef
46.
go back to reference Licastro F, Chiapelli M, Caldarera CM, et al. Acute myocardial infarction and proinflammatory gene variants. Ann N Y Acad Sci. 2007;1119:227–42.CrossRef Licastro F, Chiapelli M, Caldarera CM, et al. Acute myocardial infarction and proinflammatory gene variants. Ann N Y Acad Sci. 2007;1119:227–42.CrossRef
Metadata
Title
Characteristics of T cell receptor repertoires of patients with acute myocardial infarction through high-throughput sequencing
Authors
Zhixiong Zhong
Heming Wu
Qifeng Zhang
Wei Zhong
Pingsen Zhao
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2019
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-019-1768-8

Other articles of this Issue 1/2019

Journal of Translational Medicine 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine